157 related articles for article (PubMed ID: 37311418)
1. Pursuing the Real Vancomycin Clearance during Continuous Renal Replacement Therapy in Intensive Care Unit Patients: Is There Adequate Target Attainment?
Smeets TJL; de Geus HRH; Rietveld A; Rietdijk WJR; Koch BCP; Endeman H; Hunfeld NGM
Blood Purif; 2023; 52(7-8):652-659. PubMed ID: 37311418
[TBL] [Abstract][Full Text] [Related]
2. Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy.
Wang C; Chen J; Yang B; Li S; Zhang Y; Chen L; Wang T; Dong Y
Pharmacotherapy; 2023 Mar; 43(3):180-188. PubMed ID: 36714991
[TBL] [Abstract][Full Text] [Related]
3. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
[TBL] [Abstract][Full Text] [Related]
4. Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy.
Al-Shaer MH; Philpott CD; Droege CA; Courter JD; Healy DP; Droege ME; Ernst NE; Mueller EW; Peloquin CA
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722885
[TBL] [Abstract][Full Text] [Related]
5. The Clearance of Midazolam and Metabolites during Continuous Renal Replacement Therapy in Critically Ill Patients with COVID-19.
Smeets TJL; de Geus HRH; Valkenburg AJ; Baidjoe L; Gommers DAMPJ; Koch BCP; Hunfeld NGM; Endeman H
Blood Purif; 2024; 53(2):107-113. PubMed ID: 37926072
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Peng Y; Cheng Z; Xie F
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0082222. PubMed ID: 36005753
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
Wenzler E; Butler D; Tan X; Katsube T; Wajima T
Clin Pharmacokinet; 2022 Apr; 61(4):539-552. PubMed ID: 34792787
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.
Isla A; Rodríguez-Gascón A; Trocóniz IF; Bueno L; Solinís MA; Maynar J; Sánchez-Izquierdo JA; Pedraz JL
Clin Pharmacokinet; 2008; 47(3):173-80. PubMed ID: 18307371
[TBL] [Abstract][Full Text] [Related]
11. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
[TBL] [Abstract][Full Text] [Related]
12. A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy.
Beumier M; Roberts JA; Kabtouri H; Hites M; Cotton F; Wolff F; Lipman J; Jacobs F; Vincent JL; Taccone FS
J Antimicrob Chemother; 2013 Dec; 68(12):2859-65. PubMed ID: 23800905
[TBL] [Abstract][Full Text] [Related]
13. Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study.
Xu J; Duan L; Li J; Chen F; Xu X; Lu J; Zhuang Z; Cao Y; Yuan Y; Liu X; Sun J; Zhou Q; Shi L; Tang L
BMC Infect Dis; 2022 Aug; 22(1):667. PubMed ID: 35918657
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin therapeutic drug monitoring in patients on continuous renal replacement therapy: a retrospective study.
Liu Y; Jiang L; Lou R; Wang M; Si Q
J Int Med Res; 2022 Sep; 50(9):3000605221126871. PubMed ID: 36177821
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Krueger CK; Bruno JJ; Tverdek FP; Hernandez M; Abudayyeh A
Ann Pharmacother; 2023 Jun; 57(6):629-636. PubMed ID: 36062536
[TBL] [Abstract][Full Text] [Related]
17. Serum micronutrient levels in critically ill patients receiving continuous renal replacement therapy: A prospective, observational study.
Gundogan K; Yucesoy FS; Ozer NT; Temel S; Sahin S; Sahin GG; Sungur M; Esmaoglu A; Talih T; Yazici C; Griffith DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1141-1148. PubMed ID: 35383966
[TBL] [Abstract][Full Text] [Related]
18. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
Pea F; Viale P; Pavan F; Furlanut M
Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
[TBL] [Abstract][Full Text] [Related]
20. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
